Search hospitals > Michigan > Farmington
QUEST Research Institute
Claim this profileFarmington, Michigan 48334
Global Leader in Parkinson's Disease
Global Leader in Alzheimer's Disease
Conducts research for Multiple System Atrophy
Conducts research for Atrophy
Conducts research for Osteoarthritis
111 reported clinical trials
3 medical researchers
Summary
QUEST Research Institute is a medical facility located in Farmington, Michigan. This center is recognized for care of Parkinson's Disease, Alzheimer's Disease, Multiple System Atrophy, Atrophy, Osteoarthritis and other specialties. QUEST Research Institute is involved with conducting 111 clinical trials across 81 conditions. There are 3 research doctors associated with this hospital, such as Aaron Ellenbogen, DO, MPH, Mohammed Ibrahim, MD, and Peter LeWitt.Area of expertise
1Parkinson's Disease
Global LeaderStage I
Stage II
Stage III
2Alzheimer's Disease
Global LeaderTop PIs
Aaron Ellenbogen, DO, MPHQuest Research Institute1 year of reported clinical research
Studies Parkinson's Disease
Studies Alzheimer's Disease
19 reported clinical trials
16 drugs studied
Mohammed Ibrahim, MDQUEST Research Institute6 years of reported clinical research
Studies Ovarian Cancer
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
3 drugs studied
Peter LeWittQuest Research Institute, LLC1 year of reported clinical research
Studies Parkinson's Disease
Studies Levodopa
2 reported clinical trials
3 drugs studied
Clinical Trials running at QUEST Research Institute
Parkinson's Disease
Multiple System Atrophy
Progressive Supranuclear Palsy
Alzheimer's Disease
Atrophy
Parkinsonism
Dementia
Paralysis
Muscle Spasms
Upper Limb Spasticity
Zoledronic Acid
for Parkinson's Disease
This home-based study is a randomized (1:1) placebo-controlled trial of a single infusion of zoledronic acid-5 mg (ZA) for the prevention of fractures in men and women aged 60 years and older with Parkinson's disease and parkinsonism with at least 2 years of follow-up. A total of 3500 participants will be enrolled and randomized in the United States. Participants, follow-up outcome assessors, and study investigators will be blinded to assigned study treatment. This trial is funded by the National Institute of Aging.
Recruiting2 awards Phase 44 criteria
Lu AF28996
for Parkinson's Disease
This trial is testing a new drug called Lu AF28996 to see if it is safe and well-tolerated in people with Parkinson's disease. The study will check how the body processes the drug and if it causes any side effects. Participants will take the drug at different frequencies during the study.
Recruiting1 award Phase 1
RO7486967
for Early Parkinson's Disease
This trial tests a new drug, RO7486967, in early-stage Parkinson's Disease patients to see if it is safe and how it works in the body. It includes patients who are either new to treatment or on stable medication.
Recruiting0 awards Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at QUEST Research Institute?
QUEST Research Institute is a medical facility located in Farmington, Michigan. This center is recognized for care of Parkinson's Disease, Alzheimer's Disease, Multiple System Atrophy, Atrophy, Osteoarthritis and other specialties. QUEST Research Institute is involved with conducting 111 clinical trials across 81 conditions. There are 3 research doctors associated with this hospital, such as Aaron Ellenbogen, DO, MPH, Mohammed Ibrahim, MD, and Peter LeWitt.